Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Nat Med. 2011 May 22;17(6):676–683. doi: 10.1038/nm.2357

Figure 2. PGRPs inhibit protein (a), RNA (b), and DNA (c) synthesis.

Figure 2

(a) Incorporation 35S-methionine and 35S-cysteine into cellular proteins, (b) 3H-uridine into RNA, and (c) 3H-thymidine into DNA in S. aureus treated with PGRPs, magainin, lysostaphin, antibiotics, or BSA (control) added at 10 min is shown; 0.5 M sucrose was used to prevent osmotic lysis; means ± SEM of 3–4 experiments.

HHS Vulnerability Disclosure